Skip to content

eCEASE to Support Treatment for Parental Tobacco Use

Electronic Pediatric Office Systems to Support Treatment for Parental Tobacco Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04974736
Acronym
eCEASE
Enrollment
817
Registered
2021-07-23
Start date
2021-07-16
Completion date
2024-08-15
Last updated
2025-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Second Hand Tobacco Smoke, Smoking Cessation, Tobacco Smoking

Keywords

Family tobacco screening, Tobacco cessation

Brief summary

The proposed project aims to develop an innovative and disseminable electronic health record (iEHR)-based approach that supports optimal primary care workflows to routinely screen families for tobacco and e-cigarette use, address household smoking behavior and promote smoke-free and e-cigarette free home and car rules in a routine and effective manner in the pediatric setting. Additionally, parents enrolled in the study will be offered assistance by a community health navigator (CHN). This study aims to examine how effective the iEHR + Navigator strategy is compared to usual care control.

Interventions

BEHAVIORALiEHR + Navigator

The iEHR + Navigator intervention consists of an iEHR part of the intervention in the pediatric primary care setting which will include routine screening of families for tobacco use and treatment delivery to parents who smoke and will be linked to the child's electronic health record. The enrolled parents will also be offered support from Community Health Navigators, who will work with offices to provide customized cessation support to tobacco users, ensuring access to medications and services.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Children's Hospital of Philadelphia
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

After the intervention has been assigned at random to one practice in each of the six pairs, the intervention will be blinded at random with either the label A or the label B, and the other label will be assigned to the control practice. The statisticians will be blinded as to which of A and B is the intervention until the analyses are completed.

Intervention model description

2-arm Randomized Control Trial with a stratified cluster randomization

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Parents or legal guardians who smoke, are present at the visit, and whose child is seen by a child healthcare clinician in a participating practice. Smoker will be defined as answering yes to either of the screening questions: Have you smoked a cigarette, even a puff, in the past 7 days? and Have you smoked any other tobacco product (cigars like black and mild, hookah), even a puff, in the past 7 days?

Exclusion criteria

1. Parent/legal guardian does not speak English; 2. No telephone; and 3. Prior enrollment in the study during a previous visit.

Design outcomes

Primary

MeasureTime frameDescription
Parental Combusted Tobacco Quit Rate at 12 Months12-monthsParental 7-day combusted tobacco quit rates, as assessed by validated surveys, biochemically confirmed at 12 months between the intervention & usual care arms

Secondary

MeasureTime frameDescription
Rates of Parental Quit Attempts12-monthsRates of parents' self-reported quit attempts between the intervention & usual care control arms, assessed by validated surveys of parents
Rates of Parental Use of Pharmacotherapy or Services12-monthsRates of parental use of pharmacotherapy and Quitlines between the intervention & usual care arms, assessed by validated surveys of parents
Rates of Parental Institution of Smoking and Vaping Bans in Their Homes and Cars12-monthsRates of parental institution of smoking and vaping bans in their homes and cars between the intervention & usual care arms, assessed by validated surveys of parents
Incremental Cost Per Quit of the Intervention12-monthsEstablish the incremental cost per quit of the iEHR + Navigator vs. usual care arms
Rates of Tobacco Use Treatment Delivery36 monthsAssess the rates of tobacco treatment delivery (NRT prescription and quitline referrals) in the iEHR + Navigator arm vs. usual care, assessed by validated surveys of parents and EHR documentation

Countries

United States

Participant flow

Recruitment details

Cluster randomized controlled trial, conducted from July 2021 to August 2023 in Twelve Philadelphia region pediatric primary care practices within the Children's Hospital of Philadephia network. Parents who used combusted tobacco in the past seven days and attended a child's preventive healthcare visit were enrolled in the study.

Pre-assignment details

A two-arm parallel cluster randomized trial was conducted in 12 pediatric practices at Children's Hospital of Philadelphia. Practices were eligible if ≥10% of child patients had Medicaid and ≥40 daily visits. Eligible practices were paired based on size and estimated smoking rate, with six pairs selected to ensure sufficient size and representativeness. Within each pair, practices were randomly assigned to either the intervention or control group using computer-generated allocation.

Participants by arm

ArmCount
eCEASE (iEHR + Navigator)
iEHR + Navigator: The iEHR + Navigator intervention consists of an iEHR part of the intervention in the pediatric primary care setting which will include routine screening of families for tobacco use and treatment delivery to parents who smoke and will be linked to the child's electronic health record. The enrolled parents will also be offered support from Community Health Navigators, who will work with offices to provide customized cessation support to tobacco users, ensuring access to medications and services.
408
Usual Care Control
Usual care delivery in pediatric primary care offices.
409
Total817

Baseline characteristics

CharacteristiceCEASE (iEHR + Navigator)Usual Care ControlTotal
Age, Categorical
<=18 years
1 Participants1 Participants2 Participants
Age, Categorical
>=65 years
6 Participants3 Participants9 Participants
Age, Categorical
Between 18 and 65 years
401 Participants405 Participants806 Participants
Age, Continuous36.4 years
STANDARD_DEVIATION 8.89
35.9 years
STANDARD_DEVIATION 8.454
36.17 years
STANDARD_DEVIATION 8.67
Ethnicity (NIH/OMB)
Hispanic or Latino
40 Participants28 Participants68 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
368 Participants381 Participants749 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants2 Participants4 Participants
Race (NIH/OMB)
Asian
17 Participants3 Participants20 Participants
Race (NIH/OMB)
Black or African American
165 Participants179 Participants344 Participants
Race (NIH/OMB)
More than one race
46 Participants21 Participants67 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
4 Participants0 Participants4 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
173 Participants204 Participants377 Participants
Region of Enrollment
United States
408 participants409 participants817 participants
Sex: Female, Male
Female
335 Participants337 Participants672 Participants
Sex: Female, Male
Male
72 Participants72 Participants144 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 4080 / 409
other
Total, other adverse events
0 / 4080 / 409
serious
Total, serious adverse events
0 / 4080 / 409

Outcome results

Primary

Parental Combusted Tobacco Quit Rate at 12 Months

Parental 7-day combusted tobacco quit rates, as assessed by validated surveys, biochemically confirmed at 12 months between the intervention & usual care arms

Time frame: 12-months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
eCEASE (iEHR + Navigator)Parental Combusted Tobacco Quit Rate at 12 Months34 Participants
Usual Care ControlParental Combusted Tobacco Quit Rate at 12 Months26 Participants
Secondary

Incremental Cost Per Quit of the Intervention

Establish the incremental cost per quit of the iEHR + Navigator vs. usual care arms

Time frame: 12-months

Secondary

Rates of Parental Institution of Smoking and Vaping Bans in Their Homes and Cars

Rates of parental institution of smoking and vaping bans in their homes and cars between the intervention & usual care arms, assessed by validated surveys of parents

Time frame: 12-months

Population: Participants who completed follow-up

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
eCEASE (iEHR + Navigator)Rates of Parental Institution of Smoking and Vaping Bans in Their Homes and CarsAnyone smoked at home in the past 3 months95 Participants
eCEASE (iEHR + Navigator)Rates of Parental Institution of Smoking and Vaping Bans in Their Homes and CarsAnyone smoked in the car in the past 3 months117 Participants
Usual Care ControlRates of Parental Institution of Smoking and Vaping Bans in Their Homes and CarsAnyone smoked at home in the past 3 months101 Participants
Usual Care ControlRates of Parental Institution of Smoking and Vaping Bans in Their Homes and CarsAnyone smoked in the car in the past 3 months125 Participants
Secondary

Rates of Parental Quit Attempts

Rates of parents' self-reported quit attempts between the intervention & usual care control arms, assessed by validated surveys of parents

Time frame: 12-months

Population: Those parents who completed the follow-up survey and reported smoking a tobacco product in the last 7 days were used in the denominator.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
eCEASE (iEHR + Navigator)Rates of Parental Quit Attempts205 Participants
Usual Care ControlRates of Parental Quit Attempts189 Participants
Secondary

Rates of Parental Use of Pharmacotherapy or Services

Rates of parental use of pharmacotherapy and Quitlines between the intervention & usual care arms, assessed by validated surveys of parents

Time frame: 12-months

Population: Participants who completed the 12 month follow up

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
eCEASE (iEHR + Navigator)Rates of Parental Use of Pharmacotherapy or ServicesUsed Nicotine Replacement Therapy177 Participants
eCEASE (iEHR + Navigator)Rates of Parental Use of Pharmacotherapy or ServicesEnrolled in quitline79 Participants
eCEASE (iEHR + Navigator)Rates of Parental Use of Pharmacotherapy or ServicesEnrolled in SmokefreeTXT71 Participants
Usual Care ControlRates of Parental Use of Pharmacotherapy or ServicesUsed Nicotine Replacement Therapy59 Participants
Usual Care ControlRates of Parental Use of Pharmacotherapy or ServicesEnrolled in quitline11 Participants
Usual Care ControlRates of Parental Use of Pharmacotherapy or ServicesEnrolled in SmokefreeTXT9 Participants
Secondary

Rates of Tobacco Use Treatment Delivery

Assess the rates of tobacco treatment delivery (NRT prescription and quitline referrals) in the iEHR + Navigator arm vs. usual care, assessed by validated surveys of parents and EHR documentation

Time frame: 36 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026